Caco and HUVEC cell cytokine response to inflammatory challenge. by Christine Tataru (17628136)

Caco2 and HUVEC IL-8 response by day. by Christine Tataru (17628136)

Caco2 and HUVEC IL-6 response by day. by Christine Tataru (17628136)

Parvalbumin-positive interneurons (PV-INs) in perilesional tissue respond to optogenetic stimulation and are involved in voluntary movement, but show a decreased firing rate. by Livia Vignozzi (22430567)

<b>Cannabinoid Receptor 2 Agonism Demonstrates Therapeutic </b><b>Potential in Experimental Models of Relevance to Diabetic Retinopathy</b> by Cayla D. Ontko (21434062)

“…Cannabinoid receptor 2 (CB2) agonism has been shown to decrease inflammatory cytokine production and leukocyte recruitment and adhesion in non-ocular inflammation models, suggesting CB2 agonism could have therapeutic potential in DR. …”

Table_1_Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics.docx by Monica L. Fernández-Quintero (6178163)

“…In this study, we structurally and dynamically characterized the affinity maturation mechanism of the germline and somatically matured (PBLA8) V_NAR to better understand their function and their applicability as therapeutics. We observed a substantial rigidification upon affinity maturation, which is accompanied by a higher number of contacts, thereby contributing to the decrease in flexibility. …”

Caco2 and HUVEC CXCL-10 response by day and treatment. by Christine Tataru (17628136)

Intrathecal injection of IGF2 siRNA decreases IGF2 protein expression in the spinal cord. by Wei-Hung Chan (11785304)

Subjects:

AIM-100 reduces dsRNA silencing in body wall muscle and decreases DA neurodegeneration. by Anthony L. Gaeta (13272609)

Subjects: “…coordinating organismal responses…”

Long term genistein treatment alters biomarker response profile, but not therapeutic responsiveness. by Hu Zhang (112605)

Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research by Shinji Maeda (445222)

M^pro confers a significant reduction in growth in yeast caused by decreases in a variety of cellular proteins. by Jin Ou (16914305)

Subjects:

Intrathecal injection of IGF2 siRNA decreases IGF2 mRNA expression in the spinal cord. by Wei-Hung Chan (11785304)

Subjects:

Chart illustrates the treated groups (BM-MSC1, BM-MSC2, AD-MSC1, AD-MSC2) increasing in cell viability over replicates, while the untreated groups (Un-BM1, Un-BM2, Un-AD1, Un-AD2)... by Alani Mohanad Khalid Ahmed (22693496)

Subjects:

Therapeutic response prediction. by Yue Cui (212753)

“…<p>(A) Correlation between CMDPTMS and therapeutic response prediction. (B, C) Correlation and differential analysis of drug sensitivity for potential drugs screened from PRISM and CTRP datasets.…”

Potential CB-5082 resistance mutations characterized in this and previous studies. by Paweł P. Szczęśniak (12359841)

Subjects:

Caco2 and HUVEC cytokine response curve in traditional 2D culture. by Christine Tataru (17628136)

Loss of SID-1 and/or SID-3 functionality decreases DA neurodegeneration and improves DA neuron function. by Anthony L. Gaeta (13272609)

Subjects: “…coordinating organismal responses…”

Data_Sheet_1_Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature.docx by Anli Tong (8460537)

Data_Sheet_2_Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature.xls by Anli Tong (8460537)